No, it’s just been speculation for well over a year now due to much of the language used by Regeneron about the mab being nearly identical to ENZC’s prior language about their Covid mab. I was almost certain at one point it must be ours and it was under one of the NDA’s, bc the description was nearly identical at one point when they spoke publicly on it and also it came right after Chandra said one of the companies they had shared information with was Regeneron. Plus that Dr. Suggar guy from Regeneron had been linked with us.
I’m still 50/50 on it and I don’t usually go for the far out speculation on things. It’s possible they were waiting to announce things until the patent was granted (or reached whatever stage protects them from lawsuits) or maybe they also wanted us off the OTC before an announcement. Thought about that one too lately with all this SAGA mess.
News 
Market Data 
Discover 
AI
